Medicaid hospital costs: 7 of the top 10 are associated with low Vitamin D

Claude AI - Oct 2026

Preterm birth isn't listed as its own category, but it sits inside #1. "Liveborn" (all newborn hospital stays) is Medicaid's single most expensive inpatient condition, and preterm and low-birth-weight babies are the biggest cost driver within it.

For hospital stays paid by Medicaid in 2017, total costs were $84.4 billion. Liveborn infants came first at $8.2 billion (9.7%), followed by septicemia at $6.7 billion (7.9%). [HCUP SB #261] This 2017 brief is the most recent ranking by payer that AHRQ has published.

Rank Condition Cost Share Linked to low vitamin D? RCT support
1 Liveborn (all newborns, incl. preterm) $8.2 B 9.7% Yes: preterm, low birth weight Conflicting
2 Septicemia $6.7 B 7.9% Yes Mostly null in ICU trials
3 Respiratory failure $2.0 B 2.3% Yes Null (VIOLET)
4 Complications during childbirth $1.6 B 1.9% Partial (e.g., C-section) Weak
5 Diabetes with complications $1.6 B 1.9% Yes Modest (diabetes prevention)
6 Heart failure $1.6 B 1.9% Yes Mostly null
7 Schizophrenia spectrum $1.5 B 1.8% Yes (incl. low neonatal D) Little tested
8 Acute myocardial infarction $1.4 B 1.7% Yes D-Health: fewer MIs
9 Previous C-section $1.2 B 1.4% Weak/indirect None
10 Congenital heart anomalies $1.1 B 1.4% Limited data None

How many are associated with low vitamin D: 7 of the 10 have consistent observational associations (#1, 2, 3, 5, 6, 7, 8). One more is partial (#4), and two are weak (#9, 10). RCT evidence is much thinner. The clearest positive results are fewer heart attacks in D-Health [D-Health BMJ 2023] and slower progression from prediabetes to diabetes [Pittas 2023]. The ICU trials were null [VIOLET NEJM 2019].

Preterm birth's hidden size:

  • In 2009 national data, preterm/LBW births were about 9.1% of infant hospitalizations but 43.4% of total costs [Preterm costs by payer].
  • Applying 43% to Medicaid's $8.2B liveborn total gives roughly $3.5B. Broken out on its own, preterm/LBW would rank about #3 on Medicaid's list, behind septicemia and term newborns.
  • That estimate is probably low. Medicaid newborns had a higher preterm rate than privately insured ones (8.9% vs 8.1%) [HCUP SB #163].
  • Rehospitalizations within 28 days added another 23% of total infant costs [APHA abstract].
  • All of this is the birth hospitalization only, not lifetime cost.

Counting the pregnancy-related items as a group: Medicaid's top 20 includes four of them: liveborn, childbirth complications, previous C-section, and hypertension complicating pregnancy (#16, $951M). Together they total about $12.0B, roughly 14% of Medicaid inpatient costs.

  • 33 RCTs: preterm labor reduced 30% (RR 0.70) and preeclampsia reduced 45% [Moghib 2024]
  • 66 trials: no effect on preterm birth or preeclampsia, but gestational diabetes reduced (RR 0.65) [Yang 2024]
  • 19 RCTs (July 2026): a borderline increase in preterm risk (RR 1.13), driven mostly by one large trial in women with HIV. The authors concluded the evidence doesn't support universal supplementation [2026 meta-analysis]

That 2026 paper also says it remains open whether baseline 25(OH)D, dose, and timing change the effect. That is the opening for your loading-dose argument: most pooled trials used modest doses started mid-pregnancy.

Scope caveats: these figures are hospital costs, not payments. They exclude physician fees and outpatient care. Medicaid's biggest overall spending categories, such as long-term care and drugs, aren't on this list.

Sources:

Related in VitaminDWiki